Subscribe to thousands of academic journals for just $40/month
Read and share the articles you need for your research, all in one place.

Roxithromycin treatment of mouse chlamydial salpingitis and protective effect on fertility.

Antimicrobial Agents and Chemotherapy , Volume 35 (3): 430 – Mar 1, 1991

Details

Publisher
American Society for Microbiology
Copyright
Copyright © 1991 by the American society for Microbiology.
ISSN
0066-4804
eISSN
1098-6596
D.O.I.
10.1128/AAC.35.3.430
Publisher site
See Article on Publisher Site

Preview Only

Expand Tray Hide Tray

Roxithromycin treatment of mouse chlamydial salpingitis and protective effect on fertility.

Abstract

Roxithromycin treatment of mouse chlamydial salpingitis and protective effect on fertility. J Zana , M Muffat-Joly , D Thomas , J Orfila , J Salat-Baroux and J J Pocidalo Unité 13, Institut National de la Santé et de la Recherche Médicale, Hôpital Claude Bernard, Paris, France. ABSTRACT We used a mouse model of acute chlamydial salpingitis to evaluate the efficacy of roxithromycin in preventing irreversible inflammatory damage leading to tubal infertility. Female C3H/He mice were genitally inoculated with a human strain of Chlamydia trachomatis and then treated with roxithromycin glutamate subcutaneously. Treatment was initiated either 7 or 10 days postinfection (p.i.) and continued for 7 days at a dosage of 50 or 100 mg/kg of body weight per 24 h. The course of the disease was monitored serologically, bacteriologically, and histologically. At the end of the treatment, the mice were encaged with males and their reproductive capacity was recorded over a 19-week period. The protective effect of roxithromycin was assessed in terms of fertility parameters in comparison with values for noninfected control mice. When treatment was initiated on day 7 p.i. and given in twice-daily 25-mg/kg doses, all the mice remained fertile and the total number of offspring was similar to that of sham-infected mice (17.3 +/- 3.3 versus 17.2 +/- 2.3). When treatment was initiated on day 10 p.i. and given in a single daily dose of 50 or 100 mg/kg, 90 and 70% of the mice, respectively, remained fertile; however, in terms of total offspring, fertility was lower in the group treated with the lower dose (5.6 +/- 1.4 versus 13.0 +/- 3.8). Roxithromycin was found to be effective against C. trachomatis in the mouse genital tract, but fertility was only partially preserved when the time between infection and treatment was prolonged. CiteULike Connotea Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter What's this? « Previous | Next Article » Table of Contents This Article doi: 10.1128/​AAC.35.3.430 Antimicrob. Agents Chemother. March 1991 vol. 35 no. 3 430-435 » Abstract PDF Classifications Research Article Services Email this article to a colleague Similar articles in ASM journals Alert me when this article is cited Alert me if a correction is posted Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of AAC Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Load citing article information Citing articles via Web of Science Citing articles via Google Scholar Google Scholar Articles by Zana, J. Articles by Pocidalo, J. J. Search for related content PubMed PubMed citation Articles by Zana, J. Articles by Pocidalo, J. J. Related Content Load related web page information Social Bookmarking CiteULike Connotea Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter What's this? current issue December 2011, volume 55, issue 12 Alert me to new issues of AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2011 by the American Society for Microbiology. For an alternate route to AAC .asm.org, visit: http://intl- AAC .asm.org | More Info» var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www."); document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E")); var pageTracker = _gat._getTracker("UA-5821458-3"); pageTracker._trackPageview();
Loading next page...

Preview Only. This article cannot be rented because we do not currently have permission from the publisher.

 
/lp/american-society-for-microbiology/roxithromycin-treatment-of-mouse-chlamydial-salpingitis-and-protective-K9ZPW1YMJm